Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.

Li H, Shi Q.

Clin Pharmacokinet. 2015 May;54(5):493-501. doi: 10.1007/s40262-015-0246-6.

PMID:
25701380
2.

Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals.

Frank C, Himmelstein DU, Woolhandler S, Bor DH, Wolfe SM, Heymann O, Zallman L, Lasser KE.

Health Aff (Millwood). 2014 Aug;33(8):1453-9. doi: 10.1377/hlthaff.2014.0122.

PMID:
25092848
3.

Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.

Bradford WD, Kleit AN.

Health Econ. 2015 Jul;24(7):859-75. doi: 10.1002/hec.3067. Epub 2014 Jul 24.

PMID:
25059655
4.

Steroid-sparing properties of emollients in dermatology.

Harcharik S, Emer J.

Skin Therapy Lett. 2014 Jan-Feb;19(1):5-10.

5.

Strategies for the prescription of psychotropic drugs with black box warnings.

Stevens JR, Jarrahzadeh T, Brendel RW, Stern TA.

Psychosomatics. 2014 Mar-Apr;55(2):123-33. doi: 10.1016/j.psym.2013.08.009. Epub 2013 Dec 19. Review.

PMID:
24360525
6.

The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.

Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, Du H, Leikin JB.

Am J Gastroenterol. 2013 Jun;108(6):866-72. doi: 10.1038/ajg.2012.300.

PMID:
23735907
7.

Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study.

Fischer SH, Field TS, Gagne SJ, Mazor KM, Preusse P, Reed G, Peterson D, Gurwitz JH, Tjia J.

J Gen Intern Med. 2013 Apr;28(4):513-21. doi: 10.1007/s11606-012-2271-6. Epub 2012 Nov 15.

8.

Black box warnings: what do they mean to pharmacists and patients.

Martin CM, Borgelt L.

Consult Pharm. 2012 Jul;27(7):482-92. doi: 10.4140/TCP.n.2012.482.

PMID:
22910129
9.

Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.

Chressanthis GA, Khedkar P, Jain N, Poddar P, Seiders MG.

J Clin Hypertens (Greenwich). 2012 Jul;14(7):435-46. doi: 10.1111/j.1751-7176.2012.00651.x. Epub 2012 May 21.

PMID:
22747616
10.

Bringing greater transparency to "black box" warnings.

Buckley NA, Rossi S.

Clin Toxicol (Phila). 2011 Jul;49(6):448-51. doi: 10.3109/15563650.2011.593523.

PMID:
21824055
11.

Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.

Stepan AF, Walker DP, Bauman J, Price DA, Baillie TA, Kalgutkar AS, Aleo MD.

Chem Res Toxicol. 2011 Sep 19;24(9):1345-410. doi: 10.1021/tx200168d. Epub 2011 Jul 11. Review.

PMID:
21702456
12.

Bioidentical hormones: an evidence-based review for primary care providers.

Conaway E.

J Am Osteopath Assoc. 2011 Mar;111(3):153-64. Review.

PMID:
21464264
13.

Using time-series intervention analysis to understand U.S. Medicaid expenditures on antidepressant agents.

Ferrand Y, Kelton CM, Guo JJ, Levy MS, Yu Y.

Res Social Adm Pharm. 2011 Mar;7(1):64-80. doi: 10.1016/j.sapharm.2009.12.002. Epub 2010 Mar 2.

PMID:
21397882
14.

Pediatric oncologists' practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: a multi-site study.

Phipps S, Buckholdt KE, Fernandez L, Wiener L, Kupst MJ, Madan-Swain A, Mullins L, Robert R, Sahler OJ, Vincent N, Noll RB.

Pediatr Blood Cancer. 2012 Feb;58(2):210-5. doi: 10.1002/pbc.22788. Epub 2011 Jan 31.

PMID:
21284076
15.

Impact of implementing alerts about medication black-box warnings in electronic health records.

Yu DT, Seger DL, Lasser KE, Karson AS, Fiskio JM, Seger AC, Bates DW.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):192-202. doi: 10.1002/pds.2088. Epub 2010 Dec 28.

PMID:
21254291
16.

FDA boxed warnings: how to prescribe drugs safely.

O'Connor NR.

Am Fam Physician. 2010 Feb 1;81(3):298-303. Review.

17.

Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.

Wang LM, Wong M, Lightwood JM, Cheng CM.

Ann Pharmacother. 2010 Jan;44(1):28-34. doi: 10.1345/aph.1M475. Epub 2009 Dec 29.

PMID:
20040698
18.

Prescriber compliance with black box warnings in older adult patients.

Ricci JR, Coulen C, Berger JE, Moore MC, McQueen A, Jan SA.

Am J Manag Care. 2009 Nov 1;15(11):e103-8.

19.

Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.

Cook DM, Gurugubelli RK, Bero LA.

Drug Saf. 2009;32(11):1057-66. doi: 10.2165/11316670-000000000-00000.

PMID:
19810777
20.

Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.

Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.

Clin Ther. 2009 May;31(5):1056-63. doi: 10.1016/j.clinthera.2009.05.008.

PMID:
19539106
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk